IST-3 Analysis Finds Primary Outcome Robust While Secondary Endpoints Show Bias
A re-analysis of the Third International Stroke Trial indicates that its primary endpoint remained robust to bias, whereas secondary endpoints ...
A re-analysis of the Third International Stroke Trial indicates that its primary endpoint remained robust to bias, whereas secondary endpoints ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.